Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


BESHAR LUKE M Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 18,118 options to buy @ $8.39, valued at $152k
06/08/2023 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.85, valued at $28.5k
07/05/2022 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Bought 10,000 shares @ $3.1, valued at $31k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.5, valued at $35k
03/16/2022 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Bought 10,000 shares @ $4.25, valued at $42.5k
03/14/2022 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Bought 10,000 shares @ $4.4555, valued at $44.6k
11/19/2021 4 BESHAR LUKE M (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 40,000 options to buy @ $12.03, valued at $481.2k
Disposed/sold 6,666 options to buy @ $0
Disposed/sold 547,656 restricted stock units @ $0
07/30/2021 4 BESHAR LUKE M (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Granted 52,941 options to buy @ $17, valued at $900k
07/29/2021 3 BESHAR LUKE M (Director) has filed a Form 3 on Omega Therapeutics, Inc.
06/10/2021 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $10.51, valued at $105.1k
06/08/2021 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 10,000 options to buy @ $35.52, valued at $355.2k
01/04/2021 3 BESHAR LUKE M (Director) has filed a Form 3 on Trillium Therapeutics Inc.
06/11/2020 4 BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 9,000 options to buy @ $35, valued at $315k
06/11/2020 4/A BESHAR LUKE M (Director) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 12,399 options to buy @ $9.18, valued at $113.8k
Granted 6,676 options to buy @ $9.18, valued at $61.3k
06/02/2020 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 10,000 options to buy @ $37.66, valued at $376.6k
01/13/2020 4 BESHAR LUKE M (Director) has filed a Form 4 on ArTara Therapeutics, Inc.
Txns: Granted 168,000 shares @ $0
Granted 12,399 options to buy @ $9.18, valued at $113.8k
Granted 6,676 options to buy @ $9.18, valued at $61.3k
Granted 10,491 options to buy @ $9.18, valued at $96.3k
01/13/2020 3 BESHAR LUKE M (Director) has filed a Form 3 on ArTara Therapeutics, Inc.
06/04/2019 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 10,000 options to buy @ $43.02, valued at $430.2k
12/03/2018 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Sold 12,784 shares @ $65, valued at $831k
Exercised 12,784 options to buy @ $3.76, valued at $48.1k
11/28/2018 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Sold 1,721 shares @ $65, valued at $111.9k
Sold 18,786 shares @ $65.03, valued at $1.2M
Exercised 1,721 options to buy @ $49.45, valued at $85.1k
Exercised 883 options to buy @ $49.45, valued at $43.7k
Exercised 4,687 options to buy @ $22, valued at $103.1k
Exercised 6,250 options to buy @ $18.85, valued at $117.8k
Exercised 6,250 options to buy @ $12.74, valued at $79.6k
Exercised 716 options to buy @ $3.76, valued at $2.7k
05/30/2018 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 12,500 options to buy @ $49.45, valued at $618.1k
05/26/2017 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 12,500 options to buy @ $18.85, valued at $235.6k
06/02/2016 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 12,500 options to buy @ $12.74, valued at $159.3k
09/22/2015 4/A Form 4/A - Statement of changes in beneficial ownership of securities [Amend]
09/17/2015 4 BESHAR LUKE M (Director) has filed a Form 4 on REGENXBIO Inc.
Txns: Granted 5,208 options to buy @ $22, valued at $114.6k
02/24/2015 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Unknown transaction of 75,201 shares @ $46, valued at $3.5M
Disposed/sold 30,615 options to buy @ $38.27, valued at $1.2M
Disposed/sold 53,089 options to buy @ $8.23, valued at $436.9k
Disposed/sold 14,844 options to buy @ $8.21, valued at $121.9k
Disposed/sold 3,594 options to buy @ $8.25, valued at $29.7k
Disposed/sold 10,905 restricted stock units @ $0
Disposed/sold 7,665 restricted stock units @ $0
Disposed/sold 10,531 restricted stock units @ $0
02/20/2015 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Acquired 8,967 shares @ $0
Paid exercise price by delivering 3,148 shares @ $45.85, valued at $144.3k
Paid exercise price by delivering 1,427 shares @ $45.85, valued at $65.4k
Paid exercise price by delivering 4,789 shares @ $45.88, valued at $219.7k
Granted 10,905 restricted stock units @ $0
Exercised 3,832 restricted stock units @ $0
Exercised 10,531 restricted stock units @ $0
Exercised 3,594 options to buy @ $8.25, valued at $29.7k
Exercised 2,969 options to buy @ $8.21, valued at $24.4k
Exercised 859 options to buy @ $38.27, valued at $32.9k
02/09/2015 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Gifted 10,000 shares @ $0
12/19/2014 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Sold 52,258 shares @ $35, valued at $1.8M
Exercised 11,500 options to buy @ $3.34, valued at $38.4k
Exercised 8,906 options to buy @ $8.21, valued at $73.1k
Exercised 31,852 options to buy @ $8.23, valued at $262.1k
11/19/2014 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Sold 47,442 shares @ $30.008, valued at $1.4M
Exercised 4,848 options to buy @ $5.85, valued at $28.4k
Exercised 31,812 options to buy @ $3.34, valued at $106.3k
Exercised 10,782 options to buy @ $8.25, valued at $89k
11/04/2014 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $29, valued at $290k
10/29/2014 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Sold 30,635 shares @ $26.7539, valued at $819.6k
08/15/2014 4 BESHAR LUKE M (EVP & CFO) has filed a Form 4 on NPS PHARMACEUTICALS INC
Txns: Exercised 2,462 options to buy @ $5.85, valued at $14.4k
Exercised 51,351 options to buy @ $3.34, valued at $171.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy